We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Treatment Effects of Narrative Exposure Therapy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00660439
Recruitment Status : Unknown
Verified April 2008 by University of Bergen.
Recruitment status was:  Recruiting
First Posted : April 17, 2008
Last Update Posted : April 17, 2008
Information provided by:

April 10, 2008
April 17, 2008
April 17, 2008
May 2007
December 2009   (Final data collection date for primary outcome measure)
Psychiatric symptoms [ Time Frame: 1 and 6 months after treatment ]
Same as current
No Changes Posted
Cortisol in saliva [ Time Frame: 1 and 6 months after treatment ]
Same as current
Not Provided
Not Provided
Treatment Effects of Narrative Exposure Therapy
Treatment Effects of Narrative Exposure Therapy on Psychiatric Symptoms and Cortisol Levels in Patients With Posttraumatic Stress Disorder
This study compares Narrative Exposure Therapy with a Waiting list control group, both consists of traumatized patients with diagnosed Posttraumatic Stress Disorder. The main aim is to investigate if the patients psychiatric symptoms and levels of the stress hormone cortisol will improve more after Narrative Exposure Therapy than the Waiting list (i.e. no intervention).
In this study we want to compare Narrative Exposure Therapy (NET) to Waiting list controls. Adult patients with diagnosed Posttraumatic Stress Disorder following different types of trauma, will be included. Clinicians in psychiatric outpatient clinics will treat patients with NET, either immediately after assessment, or after a second assessment 3 months later. All patients will also be assessed 1 and 6 months after treatment completion. All patients will be assessed for psychiatric symptoms by the Mini International Neuropsychiatric Interview (version 5.0.0) and the Clinician-Administered PTSD Scale. Patients will also answer several questionnaires (IES-R, SCL-90, BDI-II, DES and UCL). Baseline level of the stress hormone cortisol will be collected in saliva for measuring the diurnal cycle. We will investigate if patients with Posttraumatic Stress Disorder will show more symptom improvement with NET than those on the waiting list (i.e. no intervention) in addition to measuring potential differences in cortisol between the groups.
Phase 2
Allocation: Non-Randomized
Intervention Model: Crossover Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Posttraumatic Stress Disorder
Behavioral: Narrative Exposure Therapy
Psychological treatment, with narration of positive and traumatic events in patients history, including "in vivo" exposure of traumatic events. The narrative is written down by the therapist.
Other Name: NET
  • Experimental: A
    Treatment group, receives Narrative Exposure Therapy immediately after first assessment. Patients are assessed 1 and 6 months after treatment.
    Intervention: Behavioral: Narrative Exposure Therapy
  • No Intervention: B
    Waiting list control group, receives no intervention for 3 months after first assessment. A second assessment is then administered and patients receives Narrative Exposure Therapy. Patients are assessed 1 and 6 months after treatment.
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
Unknown status
November 2010
December 2009   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Posttraumatic Stress Disorder (PTSD)
  • Age above 18 years
  • Understands, speaks and writes Norwegian
  • Informed, written consent

Exclusion Criteria:

  • Active psychosis
  • Active suicidality
  • Serious self mutilation
  • Active alcohol or drug abuse
  • Serious dissociative symptoms
  • Disease in nervous system or head injury
  • Hormonal disease
  • Pregnancy
Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
Contact information is only displayed when the study is recruiting subjects
NET 40
Not Provided
Not Provided
PhD Anne Marita Milde, University of Bergen, Department of Biological and Medical Psychology
University of Bergen
Norwegian Center for Violence and Traumatic Stress Studies
Study Director: Anne Marita Milde, PhD University of Bergen
University of Bergen
April 2008

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP